期刊
MEDICAL HYPOTHESES
卷 147, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.mehy.2020.110481
关键词
COVID-19; Cystic fibrosis; Endothelial dysfunction; Pulmonary disease; SARS-CoV-2 infection
Research suggests that focusing on endothelial dysfunction rather than respiratory disease in COVID-19 infection could be key in identifying therapeutic methods that stabilize the endothelium instead of the lungs.
Coronavirus disease 2019 (COVID-19) caused more than 52.775.271 million confirmed cases, 1.293.106 deaths, globally, and afflicted 208 countries, areas, or territories; and almost three months have passed since the World Health Organisation (WHO) declared COVID-19 as a pandemic. Despite the dramatic and global impact of the Coronavirus, the knowledge about the SARS-CoV-2 infection has been improved remarkably. Herein, we provided the rationale for SARS-CoV-2 infection as endothelial dysfunction rather than respiratory disease. Accordingly, we strongly invited the researchers to look beyond pulmonary injury and shift their attention from respiratory disease to endothelial disorder. This strategy could be particularly relevant to identifying therapeutic weapons stabilizing the endothelium rather than the lungs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据